Scott W. Lee
About
Scott W. Lee is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics.
According to data from OpenAlex, Scott W. Lee has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Surgery and 16 papers in Genetics. Recurrent topics in Scott W. Lee's work include Diabetes Management and Research (30 papers), Pancreatic function and diabetes (17 papers) and Diabetes and associated disorders (16 papers). Scott W. Lee is often cited by papers focused on Diabetes Management and Research (30 papers), Pancreatic function and diabetes (17 papers) and Diabetes and associated disorders (16 papers). Scott W. Lee collaborates with scholars based in United States, Ireland and Israel. Scott W. Lee's co-authors include Francine Kaufman, Bruce W. Bode, Satish K. Garg, Robert H. Slover, Richard M. Bergenstal, Timothy S. Bailey, John Shin, Ronald Brazg, John Welsh and Andrew Ahmann and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Diabetes.
In The Last Decade
Scott W. Lee
31 papers receiving 1.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Scott W. Lee United States | 18 | 1.7k | 1.2k | 1.0k | 74 | 55 | 31 | 1.8k | ||
| Kavita Kumareswaran United Kingdom | 20 | 1.2k 0.7× | 905 0.7× | 701 0.7× | 64 0.9× | 63 1.1× | 32 | 1.3k | ||
| Daniela Elleri United Kingdom | 24 | 1.8k 1.1× | 1.4k 1.1× | 1.1k 1.1× | 67 0.9× | 66 1.2× | 54 | 2.1k | ||
| Monika Reddy United Kingdom | 23 | 1.1k 0.7× | 713 0.6× | 655 0.6× | 111 1.5× | 71 1.3× | 66 | 1.4k | ||
| Robert H. Slover United States | 21 | 2.2k 1.3× | 1.7k 1.4× | 1.5k 1.5× | 69 0.9× | 57 1.0× | 36 | 2.4k | ||
| Peter Calhoun United States | 24 | 1.5k 0.9× | 1.0k 0.8× | 949 0.9× | 52 0.7× | 72 1.3× | 90 | 1.7k | ||
| Sara Hartnell United Kingdom | 19 | 1.3k 0.8× | 925 0.8× | 771 0.8× | 34 0.5× | 42 0.8× | 49 | 1.4k | ||
| Ahmad Haidar Canada | 27 | 2.0k 1.2× | 1.6k 1.3× | 1.1k 1.1× | 73 1.0× | 97 1.8× | 71 | 2.2k | ||
| Torben Biester Germany | 22 | 1.5k 0.9× | 1.0k 0.9× | 952 0.9× | 35 0.5× | 51 0.9× | 77 | 1.7k | ||
| Revital Nimri Israel | 25 | 2.1k 1.2× | 1.8k 1.5× | 1.5k 1.5× | 66 0.9× | 56 1.0× | 50 | 2.4k | ||
| Firas H. El-Khatib United States | 18 | 1.6k 0.9× | 1.3k 1.1× | 921 0.9× | 137 1.9× | 67 1.2× | 30 | 1.8k |
Countries citing papers authored by Scott W. Lee
Since
Specialization
Citations
This map shows the geographic impact of Scott W. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott W. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott W. Lee more than expected).
Fields of papers citing papers by Scott W. Lee
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Scott W. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott W. Lee. The network helps show where Scott W. Lee may publish in the future.
Co-authorship network of co-authors of Scott W. Lee
This figure shows the co-authorship network connecting the top 25 collaborators of Scott W. Lee. A scholar is included among the top collaborators of Scott W. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott W. Lee. Scott W. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Yu, Pei, Weijian Ke, Jing Lü, et al.. (2023). Safety Event Outcomes and Glycemic Control with a Hybrid Closed-Loop System Used by Chinese Adolescents and Adults with Type 1 Diabetes Mellitus. Diabetes Technology & Therapeutics. 25(10). 718–725.
2.
Forlenza, Gregory P., Laya Ekhlaspour, Linda A. DiMeglio, et al.. (2022). Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed ™ 670G system trial. Pediatric Diabetes. 23(3). 324–329.
3.
Forlenza, Gregory P., Orit Pinhas‐Hamiel, David R. Liljenquist, et al.. (2018). Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(1). 11–19.
4.
Wood, Michael A., Dorothy I. Shulman, Gregory P. Forlenza, et al.. (2018). In-Clinic Evaluation of the MiniMed 670G System “Suspend Before Low” Feature in Children with Type 1 Diabetes. Diabetes Technology & Therapeutics. 20(11). 731–737.
5.
Vigersky, Robert A., Suiying Huang, Toni L. Cordero, et al.. (2018). IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS. Endocrine Practice. 24(5). 446–452.
6.
Slover, Robert H., Jeanie B. Tryggestad, Linda A. DiMeglio, et al.. (2018). Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes. Diabetes Technology & Therapeutics. 20(9). 576–584.
7.
Chlup, Rudolf, et al.. (2017). Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction. Diabetes Technology & Therapeutics. 20(2). 153–159.
8.
Cordero, Toni L., Satish K. Garg, Ronald Brazg, et al.. (2017). The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed ™ 670G Hybrid Closed-Loop System. Diabetes Technology & Therapeutics. 19(12). 749–752.
9.
Bailey, Timothy S., Andrew Ahmann, Ronald Brazg, et al.. (2014). Accuracy and Acceptability of the 6-Day Enlite Continuous Subcutaneous Glucose Sensor. Diabetes Technology & Therapeutics. 16(5). 277–283.
10.
Reznik, Yves, Ohad Cohen, Ronnie Aronson, et al.. (2014). Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. The Lancet. 384(9950). 1265–1272.
11.
Danne, Thomas, Olga Kordonouri, K Remus, et al.. (2014). The PILGRIM Study: In Silico Modeling of a Predictive Low Glucose Management System and Feasibility in Youth with Type 1 Diabetes During Exercise. Diabetes Technology & Therapeutics. 16(6). 338–347.
12.
Bergenstal, Richard M., David C. Klonoff, Satish K. Garg, et al.. (2013). Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia. New England Journal of Medicine. 369(3). 224–232.
13.
Klonoff, David C., Richard M. Bergenstal, Satish K. Garg, et al.. (2013). ASPIRE in-Home: Rationale, Design, and Methods of a Study to Evaluate the Safety and Efficacy of Automatic Insulin Suspension for Nocturnal Hypoglycemia. Journal of Diabetes Science and Technology. 7(4). 1005–1010.
14.
Keenan, D. Barry, John J. Mastrototaro, Howard Zisser, et al.. (2011). Accuracy of the Enlite 6-Day Glucose Sensor with Guardian and Veo Calibration Algorithms. Diabetes Technology & Therapeutics. 14(3). 225–231.
15.
Brazg, Ronald, Timothy S. Bailey, Satish K. Garg, et al.. (2011). The ASPIRE Study: Design and Methods of an In-Clinic Crossover Trial on the Efficacy of Automatic Insulin Pump Suspension in Exercise-Induced Hypoglycemia. Journal of Diabetes Science and Technology. 5(6). 1466–1471.
16.
Lynch, Peter, et al.. (2010). Resource utilization with insulin pump therapy for type 2 diabetes mellitus.. PubMed. 16(12). 892–6.
17.
Lynch, Peter, et al.. (2010). Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysis. Primary care diabetes. 4(4). 209–214.
18.
Banta, Jim E., Elaine H. Morrato, Scott W. Lee, & Mark G. Haviland. (2009). Retrospective Analysis of Diabetes Care in California Medicaid Patients with Mental Illness. Journal of General Internal Medicine. 24(7). 802–808.
19.
Lee, Scott W., et al.. (2007). Combined Insulin Pump Therapy with Real-Time Continuous Glucose Monitoring Significantly Improves Glycemic Control Compared to Multiple Daily Injection Therapy in Pump Naïve Patients with Type 1 Diabetes; Single Center Pilot Study Experience. Journal of Diabetes Science and Technology. 1(3). 400–404.
20.
Lee, Scott W., et al.. (2004). Current Perspectives on the Use of Continuous Subcutaneous Insulin Infusion in the Acute Care Setting and Overview of Therapy. Critical Care Nursing Quarterly. 27(2). 172–184.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kavita Kumareswaran Breakdown of academic impact, for papers by Daniela Elleri Breakdown of academic impact, for papers by Monika Reddy Breakdown of academic impact, for papers by Robert H. Slover Breakdown of academic impact, for papers by Peter Calhoun Breakdown of academic impact, for papers by Sara Hartnell Breakdown of academic impact, for papers by Ahmad Haidar Breakdown of academic impact, for papers by Torben Biester Breakdown of academic impact, for papers by Revital Nimri Breakdown of academic impact, for papers by Firas H. El-Khatib